rs201736972
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000384.3(APOB):c.10708C>T(p.His3570Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000149 in 1,613,882 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000384.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
APOB | NM_000384.3 | c.10708C>T | p.His3570Tyr | missense_variant | 26/29 | ENST00000233242.5 | NP_000375.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
APOB | ENST00000233242.5 | c.10708C>T | p.His3570Tyr | missense_variant | 26/29 | 1 | NM_000384.3 | ENSP00000233242 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152124Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000124 AC: 31AN: 250924Hom.: 0 AF XY: 0.000148 AC XY: 20AN XY: 135574
GnomAD4 exome AF: 0.000145 AC: 212AN: 1461758Hom.: 0 Cov.: 36 AF XY: 0.000144 AC XY: 105AN XY: 727174
GnomAD4 genome AF: 0.000191 AC: 29AN: 152124Hom.: 0 Cov.: 33 AF XY: 0.0000942 AC XY: 7AN XY: 74300
ClinVar
Submissions by phenotype
not provided Uncertain:3Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Mar 29, 2021 | Reported in patients in association with hypercholesterolemia, hyperlipidemia, coronary heart disease and/or myocardial infarction in published literature (Soufi et al., 2004; Basistova et al., 2007; Liyanage et al., 2008; Kusters et al., 2013; Klancar et al., 2015; Galaska et al., 2016; Mullertz et al., 2018; Juhasz et al., 2020); however, while the variant segregated with disease in some families, it has also been identified in unaffected relatives and is absent in other affected relatives; Also described as H3543Y due to alternate nomenclature; In silico analysis supports that this missense variant does not alter protein structure/function; Reported in ClinVar but additional evidence is not available (ClinVar Variant ID#431988; Landrum et al., 2016); This variant is associated with the following publications: (PMID: 18325181, 15135245, 26666465, 29598884, 26361156, 23833242, 17046772, 33489595) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 22, 2021 | The p.His3570Tyr variant (also reported as p.His3543Tyr) in APOB has been reported in 7 individuals with hypercholesterolemia, one individual with suspected hypercholesterolemia, one individual with sudden cardiac death and segregated with disease in 3 affected relatives from 2 families, but was not detected in one affected family member (Soufi 2004, Basistova 2007, Liyanage 2008, Galaska 2016, Mullertz 2018). This variant has also been identified in 0.027% (35/128752) of European chromosomes by gnomAD (http://gnomad.broadinstitute.org) and is reported in ClinVar (Variation ID: 431988). This frequency is low enough to be consistent with the frequency of familial hypercholesterolemia in the general population. Histidine (His) at position 3570 is not conserved in mammals or evolutionarily distant species, and 3 mammals (squirrel, ferret, and Chinese hamster) and 18 other species carry a Tyrosine (Tyr), raising the possibility that this change may be tolerated. Additional computational prediction tools analysis suggest that the p.His3570Tyr variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, while there is some suspicion for a pathogenic role, the clinical significance of the p.His3570Tyr variant is uncertain due to conflicting data. ACMG/AMP Criteria applied: PS4_Moderate, BP4_Strong, BS4. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | May 04, 2023 | BS4, BP4_strong, PS4_moderate - |
Likely benign, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Nov 18, 2021 | - - |
Hypercholesterolemia, autosomal dominant, type B Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory of molecular diagnosis of dyslipidemias, Università egli studi di Napoli Federico II | May 24, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University of Leipzig Medical Center | Sep 23, 2021 | - - |
Hypercholesterolemia, autosomal dominant, type B;C4551990:Familial hypobetalipoproteinemia 1 Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 02, 2021 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 13, 2024 | - - |
Hypercholesterolemia, familial, 1 Pathogenic:1
Pathogenic, no assertion criteria provided | research | Laboratorium voor Moleculaire Diagnostiek Experimentele Vasculaire Geneeskunde, Academisch Medisch Centrum | - | - - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 07, 2023 | The p.H3570Y variant (also known as c.10708C>T), located in coding exon 26 of the APOB gene, results from a C to T substitution at nucleotide position 10708. The histidine at codon 3570 is replaced by tyrosine, an amino acid with similar properties. This variant (also referred to as H3543Y) has been described in several patients with familial hypercholesterolemia (FH), and a sudden death victim with myocardial infarction (Soufi M et al. Atherosclerosis. 2004;174(1):11-6; Liyanage KE et al. Ann Clin Biochem. 2008;45(Pt 2):170-6; Müllertz KM. Int. J. Cardiol. 2018 07;262:45-50). In a family study, this variant was observed in two relatives with hypercholesterolemia; however, this variant also was seen in a relative with normal LDL-cholesterol, and not reported in a relative with primary hypercholesterolemia and tendon xanthomatosis (Basistová Z et al. Atherosclerosis. 2007;194(2):e185-7). In a recent family study, this variant was reported in an individual with FH, who also had an LDLR mutation detected; her similarly affected daughter had only the LDLR variant (Juhász L et al. Cureus, 2020 Dec;12:e12184). This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 08, 2024 | Variant summary: APOB c.10708C>T (p.His3570Tyr) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00012 in 250924 control chromosomes. The observed variant frequency is approximately 2-fold of the estimated maximal expected allele frequency for a pathogenic variant in APOB causing Familial Hypercholesterolemia phenotype (6.3e-05). c.10708C>T has been reported in the literature in individuals affected with Familial Hypercholesterolemia, without strong evidence for causality (Soufi_2004, Basistovs_2007, Liyanage_2008, Varret_2008, Toton-Zuranska_2023). These report(s) do not provide unequivocal conclusions about association of the variant with Familial Hypercholesterolemia. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 17046772, 18325181, 15135245, 36648309, 18028451). ClinVar contains an entry for this variant (Variation ID: 431988). Based on the evidence outlined above, the variant was classified as likely benign. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at